Delivery Order SPE2DB20D1100-SPE2DB25FE1S3
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is for the delivery of TLANDO 112.5 MG CAPSULE 120S, a medical product. The contract has a firm fixed price of $1,011.22 and an ultimate completion date of June 5, 2025. The award was made on June 4, 2025, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,233.81 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 120 capsules of the pharmaceutical product TLANDO 112.5 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows DLA to efficiently procure...
- The Defense Logistics Agency awarded a delivery order valued at $22,892.70 to AmerisourceBergen Drug Corp for the supply of Tadliq 20 mg/5 ml suspension (150 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.43 to AmerisourceBergen Drug Corp for the supply of TADLIQ 20 mg/5 ml suspension in 150ml quantities. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,578.09 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. The contract, issued on August 14, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp on August 5, 2025, for pharmaceutical products and medical supplies. This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at the...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $111,086.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive award, which carries no set-aside designation, is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,525.30 to AmerisourceBergen Drug Corp on August 14, 2025, for pharmaceutical and medical supply products. This non-set-aside, firm fixed price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $117,365.33 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 16, 2025, with an ultimate completion date of August 18, 2025. The contract represents a child award under AmerisourceBergen's broader relationship with the federal government's military healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $76,047.40 to AmerisourceBergen Drug Corp on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $1 billion ceiling through December 2026. The vendor, headquartered in Conshohocken,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1S3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,033.66 to AmerisourceBergen Drug Corp for TLANDO 112.5 mg capsules (120 count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same municipality. AmerisourceBergen Drug Corp serves as a critical vendor in the federal medical supply chain, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. As a major pharmaceutical distributor holding significant federal contracts with the Defense Logistics Agency and other government healthcare entities, the company demonstrates capability to meet federal procurement requirements through competitive bidding. The awarded delivery order for TLANDO capsules reflects the company's continued role in supporting the Defense Health Agency and other federal customers through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/20/25 |